PharmaSentinel Partners with Pay10 for Medsii.com Expansion

PharmaSentinel Limited has announced a license agreement with Pay10 for its AI-driven platform Medsii.com, enhancing healthcare analytics capabilities.

PharmaSentinel Limited has announced a significant license agreement with Pay10 for its flagship product, Medsii.com, announced in a press release. This partnership allows PharmaSentinel to further develop its AI-driven digital health solutions, while enabling Pay10 to enhance its intelligence services.

Medsii.com is a B2B platform that leverages AI to provide comprehensive scientific, clinical, regulatory, and competitive intelligence. This collaboration is expected to help PharmaSentinel capitalize on the growing healthcare analytics market, which is expanding at a 20% CAGR.

The agreement will also allow Pay10 to offer enhanced insights and regulatory support to its global users, driving innovation and improving data accessibility for stakeholders worldwide. Terms of the agreement remain confidential.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.

Also, consider following us on social media:

AI Brief
AI Brief (X)

More from: Healthcare & Life Sciences

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Sponsored

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like